|
Match
|
Document |
Document Title |
|
|
5354868 |
Process for the preparation of (+)-hydantocidin and analogs thereof
Hydantocidin is a potent non-selective herbicidal natural product. This invention provides an efficient method for the enantioselective preparation of (+)-hydantocidin, analogs thereof and...
|
|
|
5354852 |
Polysaccharide derivative, process for producing the same, and separating agent
A particulate aromatic or araliphatic carbamate of a polysaccharide having a mean particle diameter of 1 to 200 μm and a specific surface area of 0.5 to 300 m 2 /g is prepared by first dissolving...
|
|
|
5350841 |
Ganglioside derivatives
Novel ganglioside derivatives comprised of a basic natural or semisynthetic ganglioside, in which the carboxyl group in the sialic part of the natural or semisynthetic ganglioside is converted into...
|
|
|
5342976 |
Skin treatment composition
A composition suitable for topical application to human skin comprises, in addition to a suitable vehicle an active ingredient which can control skin barrier functions. The active ingredient is (a)...
|
|
|
5332812 |
Solid-phase substrate containing modified heparin
A solid phase substrate which yields soluble labeled products upon hydrolysis by a glycosaminoglycan endoglycosidase and methods of producing said substrate are comprised in the present invention....
|
|
|
5330977 |
Di-N-acetyl lysoganglioside compositions
The invention relates to N-deacetyl-lysogangliosides and physiologically acceptable salts thereof, especially those of formula (I): ##STR1## wherein R represents --CHCH(CH 2 )nCH 3 or --CH 2 ...
|
|
|
5321012 |
Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
Nontoxic substances that block the N-methyl-D-aspartate (NMDA) receptor, e.g., a morphinan such as dextromethorphan or dextrorphan, or that block a major intracellular consequence of NMDA receptor...
|
|
|
5321011 |
Pentasaccharide phytohormones and methods for their use
A phytohormone for inducing root hair curling and root nodulation in the roots of leguminous plants particularly in the absence of nitrogen-fixing bacteria. The phytohormone comprises a...
|
|
|
5284941 |
Process for obtaining glycolipids and phospholipids
Glycolipids and phospholipids are obtained by dissolving a mixture of complex lipids in a solvent to form a solution and then passing the solution over a boric acid gel. Glycolipids are retained in...
|
|
|
5281702 |
Di-N-deacetyl-lysogangliosides
The invention relates to N-deacetyl-lysogangliosides and physiologically acceptable salts thereof, especially those of formula (I): ##STR1## wherein R represents --CHCH(CH 2 )nCH 3 or --CH 2 ...
|
|
|
5280016 |
Non-anticoagulant heparin derivatives
A non-anticoagulant (NAC) form of heparin which shows antiproliferative activity with respect to smooth muscle cells is useful in the prevention of restenosis and other conditions benefited by...
|
|
|
5278300 |
4,6-o-hydroxyphosphoryl-glucosamine derivatives
4,6-O-hydroxyphosphoryl-glucosamine derivatives as shown in the following formula [I] and their pharmaceutically-acceptable salts: ##STR1## wherein R 1 and R 2 represent a hydrogen atom or a...
|
|
|
5278299 |
Method and composition for synthesizing sialylated glycosyl compounds
|
|
|
5275939 |
Process for producing asialo GM1
The present invention provides a process for preparing asialo G M1 characterized in that neuraminidase isozyme L is allowed to act on gangliosides to produce asialo G M1 .
|
|
|
5273892 |
Acid heteropolysaccharide, sulfated polysaccharide and process for producing the same
An acid heteropolysaccharide P-318 which comprises galactose, galacturonic acid, N-acetylfucosamine and pyruvic acid in a ratio of about 2:3:1:1, a sulfated heteropolysaccharide P-318 having a 10%...
|
|
|
5274086 |
N-acetyl-β-d-glucosamine derivatives and reagents for determining n-acetyl-β-d-glucosaminidase activity containing the same as effective ingredients
N-Acetyl-β-D-glucosamine derivatives represented by the formula ##STR1## wherein R 1 denotes a substituted alkyl group of 1 to 4 carbon atoms having a hydroxyl group, carboxyl group, sulfonic...
|
|
|
5264567 |
GM.sub.3 analogous compound
GM 3 analogous compound (I) below: ##STR1## wherein one of R 2 and R 3 represents a neuramic acid group represented by general formula (V): ##STR2## R 5 represents ##STR3## or hydrogen; R 6 ...
|
|
|
5254533 |
Elfamycin
A compound of the elfamycin family, a process for preparing it and its use in the feeding of monogastric animals.
|
|
|
5252728 |
Process for obtaining polymers with antiviral activity
The present invention consists in a process for obtaining polymers with antiviral activity which is characterized in that beginning with oligo or polysaccharides with a specific structure, polymers...
|
|
|
5250672 |
Contrast agent for NMR imaging
A polysaccharide chemically joined to a nitroxyl spin label (NSL) compound has use for the preparation of an NMR diagnostic composition. An agent for modifying H 2 O relaxation times in NMR...
|
|
|
5231177 |
Sodium N-acetylneuraminate trihydrate
Sodium N-acetylneuraminate trihydrate herein provided is represented by the following formula: ##STR1## The sodium N-acetylneuraminate trihydrate can be prepared, for instance, according to a...
|
|
|
5229373 |
Use of exogenous gangliosides as a protective factor against toxicity by antitumor drug vincristine
An agent for prevention or prophylaxis of general toxic effects or chronic neurotoxic effects which are caused by the administration of antineoplastic agents, which is to be given to patients prior...
|
|
|
5218098 |
5-(α-D-glucopyranosyloxymethyl)-furan-2-carboxaldehyde
5-(α-D-glucopyranosyloxymethyl)-furan-2-carboxaldehyde (GMF) is produced from isomaltulose by heating a solution of isomaltulose in a strongly polar aprotic solvent in the presence of an acidic...
|
|
|
5218094 |
Neuronotrophic factor derived from mammalian brain tissue
A novel neuronotrophic factor having a molecular weight of about 14,000 to 17,000 daltons and an isoelectric point of about 10 is prepared by homogenization of mammalian brain tissue, particularly...
|
|
|
5210072 |
Muramyl dipeptide derivatives
The 3-O-[N-acetylmuramyl-D-isoglutaminyl]-1,2-di-O-palmitoyl-sn-
glycerol derivative of formula I ##STR1## wherein the carbon atom marked with an asterisk * has the R or, respectively, the S...
|
|
|
5210078 |
Trifluoromethyl analogs of fucose and uses thereof
The present invention discloses trifluorofucoses and methods of making the same. Also disclosed are trifluorofucose analogs of fucose-containing oligosaccharides, and conjugates of trifluorofucose....
|
|
|
5208326 |
8-hydroxy-2H-dibenz(b,f)azepin-2-one dyes
Disclosed are 8-Hydroxy-2H-dibenz[b,f]azepin-2-one dyes, chromogenic enzyme substrates made from them and methods for preparing the same.
|
|
|
5206356 |
Inhibitors for alpha-L-fucosyl transferase
Synthetic glycosaminosyl transferase-V acceptors and inhibitors are disclosed. Minimal trisaccharide inhibitors and acceptors specific for GnT-V, which is associated with the ability of cells to...
|
|
|
5198352 |
Preparation of antibacterial compositions from glycopeptides
Antibacterially active compositions are prepared from a proteolytic enzymatic digestate of glycopeptides obtained from a protein isolate enriched with soya glycoprotein 7S or with bean glycoprotein...
|
|
|
5192748 |
Antibiotics unphenelfamycin and phenelfamycins A-D
New antibiotics, unphenelfamycin and phenelfamycins A-D, are produced by microorganisms belonging to the genus Streptomyces. The antibiotics have antibacterial activity against gram-positive and...
|
|
|
5191072 |
Lipid A monosaccharide analogues
Lipid A monosaccharide analogues of the following general formula: ##STR1## wherein R 1 is a hydrogen atom or a hydroxyl group, 1 is an integer of 8-14, m is an integer of 11-17 integer, and n is...
|
|
|
5188769 |
Process for reducing the levels of fatty acid contaminants in polyhydroxy fatty acid amide surfactants
The synthesis of polyhydroxy fatty acid amide surfactants exemplified by the compound C 11 H 23 C(O)N(CH 3 )CH 2 [CHOH] 4 CH 2 OH by reacting a fatty acid ester with an N-alkyl sugar amine can...
|
|
|
5179093 |
Quinoline-diones
Compounds of the formula ##STR1## or a pharmaceutically acceptable salt thereof wherein, R is H, halogen, (C 1 -C 6 ) alkyl, N(C 1 -C 6 alkyl/aryl) 2 , OH, O--(C 1 -C 6 ) alkyl/aryl, CH 2 OH,...
|
|
|
5158941 |
Lipid A analog as stimulant for production of interleukin-1 in human monocytes and tumor cell growth inhibitor
This invention concerns the use of synthetic Lipid A analog P9132 to activate human monocytes, and inhibit growth of tumor cells.
|
|
|
RE34091 |
Sialic acid derivatives having active carbonyl group
A sialic acid derivative having an active carbonyl group represented by the formula [I]: ##STR1## wherein R 1 represents hydrogen or acetyl group; R 2 represents hydrogen, a metal or a lower...
|
|
|
5143841 |
Ganglioside ceramidase and process for producing same
This invention provides a novel ganglioside ceramidase which has a substrate specificity at least for GD1a, GM1, GM2 and GM3 and acts at least on GD1a, GM1, GM2 and GM3 and catalyzes the reaction...
|
|
|
5134230 |
2-Deoxy-2-aminoglucopyranoside derivatives
A disaccharide compound represented by formula (I): ##STR1## wherein R, R 1 , R 2 , R 3 , R 4 , and R 5 are as defined in the specification and a salt thereof are disclosed. The compound exhibits...
|
|
|
5126330 |
Sialosyl cholesterol and neuropathy remedy comprising the same
The present invention relates to a sodium salt of sialosyl cholesterol. The present compound has an excellent high water solubility, and therefore the compound is very useful as a medicine to be...
|
|
|
5120839 |
Amido-linked oligosaccharide alditols and a process for their manufacture
The invention relates to amido-linked oligosaccharide alditols, i.e. oligosaccharide alditols with an amido linkage, having the general formula ##STR1## wherein: R 1 =the alditol portion of a...
|
|
|
5104855 |
Demethylallosamidin and a process for production thereof
An antifungal compound, demethylallosamidin, represented by the formula: ##STR1## is disclosed. Methods of production and antifungal compositions comprising demethylallosamidin are also provided.
|
|
|
5102883 |
Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
The pyrimidine biosynthesis inhibitors dichloroallyl lawsone, N-(phosphonoacetyl)-L-aspartic acid (PALA), pyrazofurin, and derivatives thereof, are useful as immunomodulatory and anti-inflammatory...
|
|
|
5101026 |
Ganglioside related compounds and method of producing the same
The present invention relates to ganglioside related compounds having, for example, the following formula: ##STR1## where R 1 represents H or COCH 3 (hereinafter abbreviated to "AC"); R 2 ...
|
|
|
5077397 |
Sialic acid derivative with active ester groups
Sialic acid derivative with active ester groups expressed with the formula [I] ##STR1## Where R 1 denotes hydrogen or an acetyl group, R 2 denotes hydrogen or a lower alkyl group, R 3 denotes C...
|
|
|
5077277 |
Chemical derivatives of antibiotics LL-E19020 alpha and beta
Derivatives of antibiotics derived from the microorganism Streptomyces lydicus subspecies tanzanius, referred to as antibiotics LL-E19020 alpha and beta, are produced by chemical reaction. The...
|
|
|
5066794 |
Process for preparing a disaccharide derivative
Disaccharide derivatives represented by the formula (I): ##STR1## wherein R 1 CO-- and R 2 CO-- each represents a residue of a straight chain fatty acid having from 8 to 20 carbon atoms and...
|
|
|
5045338 |
Secondary amide esters as low calorie fat mimetics
Secondary amide esters of the general formula ##STR1## where A is an organic radical having 2 to 6 carbons, m=1 to 3, n=1 to 3, and each R is, independently, an aliphatic, ether or ester group...
|
|
|
5045532 |
Inner esters of gangliosides with analgesic-antiinflammatory activity
A pharmaceutical composition is provided comprising inner ester ganglioside derivatives useful for its peripheral analgesic-antiinflammatory activity in treating pain caused by pathologies of the...
|
|
|
5041427 |
Lipid A derivatives
Compounds are disclosed which are useful in a method of treating animals to protect them from the toxic effects of Gram negative endotoxin. They include the diphosphoryl lipid A (DPLA) which can be...
|
|
|
5037973 |
Bis-aldonamides and process for their preparation
The invention relates to bisaldonamides, in which the underlying aldonic acids can be linked glycosidically in the 3-, 4- or 6-position with a galactopyranosyl, mannopyransyl, glucopyranosyl or...
|
|
|
5034516 |
Synthetic antigens of sialic acid and derivatives thereof
A compound X-Y wherein X comprises sialic acid, a sialic acid derivative or an oligosaccharide terminating in a sialic acid or sialic acid derivative if multibranched at the end of at least the...
|